Xenon Pharmaceuticals (XENE) Stock
Xenon Pharmaceuticals (XENE) has a Tenet Score of 44 of 100 against 340 Healthcare peers, as of Nov 16, 2026.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Market cap
- $3.9B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 33.38 – 72.66
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 44/100
- Weak · 340 Healthcare peers
Industry: Drugs
Xenon Pharmaceuticals Inc scores 44/100. Weak. Strongest on financial health, growth is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Pha…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Definium Therapeutics Inc.DFTX | 50 | $4.1B |
| CRISPR Therapeutics AGCRSP | 64 | $3.9B |
| Tarsus Pharmaceuticals IncTARS | 34 | $3.9B |
| Relay Therapeutics IncRLAY | 43 | $3.8B |
| Organon & Co.OGN | 45 | $3.7B |
| Amylyx Pharmaceuticals IncAMLX | 56 | $3.6B |
| Enliven Therapeutics IncELVN | 60 | $3.5B |
| Iovance Biotherapeutics IncIOVA | 52 | $3.5B |
| Arcutis Biotherapeutics IncARQT | 43 | $3.4B |
| Viking Therapeutics IncVKTX | 36 | $3.4B |
Common questions
What sector and industry is Xenon Pharmaceuticals in?
Xenon Pharmaceuticals is in the Healthcare sector and the Drugs industry.
What is Xenon Pharmaceuticals' Tenet Score?
Xenon Pharmaceuticals' Tenet Score is 44 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




